Vis enkel innførsel

dc.contributor.advisorMelberg, Hans Olav
dc.contributor.authorKarn, Rupesh
dc.date.accessioned2024-12-06T14:06:08Z
dc.date.available2024-12-06T14:06:08Z
dc.date.issued2023-12-01
dc.description.abstract<p>Introduction: Since 2001, due to the change in the Pharmacy Act, the accessibility of pharmacies to the public has considerably increased due to the increase in the number of pharmacies owned by chain wholesalers. In terms of pharmaceutical brands, competition serves as a driving force that compels brands to make new, effective, and enhanced medicines while encouraging generic companies to provide more cost-effective alternatives (2). In Norway, 5,200 inhabitants per pharmacy were getting services from the pharmacies, irrespective of their brands, in 2022. <p>Methodology: This thesis followed a cross-sectional study design and utilized the statistical database related to revenue and profit from Norway. Whereas, total population residing in the respective municipalities from Statens Legemiddelverk. Analyses consist of descriptive statistics for baseline characteristics. A one-way ANOVA was calculated for the p-value. Similarly, the main results went through linear regression analysis. <p>Results: Among all pharmacies in Norway, most made (2.3±2.9) percent of their total revenue as profit. “Competition of pharmacy” was a significant predictor variable [Bcrude = -0.395, 95% C.I. = (-0.752) - (-0.038)] at the 5% level, suggesting a negative relationship with “profit percentage." After nullifying the confounders, the result showed that there was still a significant relationship between “profit percentage” and “competition of pharmacy” [badjusted = -1.650, 95% C.I. = (-2.611) - (-0.690)] at the 5% level. Similarly, “competition of pharmacy” was a significant predictor variable [Bcrude = 1,931, 95% C.I. = 1.591–2.271] at the 5% level, suggesting a positive relationship with “total revenue per capita." After adjusting other variables, the result showed that there was still a significant relationship between “total revenue of pharmacy” and “competition of pharmacy” [Badjusted = 2.027, 95% C.I. = 1.690–2.364] at the 5% level. <p>Conclusion: From this thesis it can be concluded that with the increase in competition among the pharmacies there will be less profit gained by the pharmacies. On the contrary, the positive association was observed between competition among the pharmacies and revenue per capita of pharmacies in Norway, which showed that with the increase in competition, revenue per capita will also increase.en_US
dc.identifier.urihttps://hdl.handle.net/10037/35902
dc.language.isoengen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2023 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)en_US
dc.subject.courseIDHEL-3950
dc.subjectPharmacyen_US
dc.subjectProfiten_US
dc.subjectRevenueen_US
dc.titleImpact of competition on profit and revenue of pharmacies in Norwayen_US
dc.typeMaster thesisen_US
dc.typeMastergradsoppgaveen_US


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)